Product Images Minocycline Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Minocycline Hydrochloride NDC 70771-1156 by Zydus Lifesciences Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
figure - 501b1d9e de62 4f0c 9233 fa7af6df2057 01
figure - 501b1d9e de62 4f0c 9233 fa7af6df2057 02
This is a description of the prescription medication, Minocycline Hydrochloride, in extended-release tablet form. Each tablet contains 45mg of minocycline hydrachloride USP. The organic impurities procedure is still pending according to USP standards. The recommended dosage is available in the package insert. The medication should be stored at a controlled room temperature of 20° to 25°C (88° to 77°F) and protected from light, moisture, and excessive heat. This medication should be kept out of reach of children and dispensed in a tight, light-resistant container as defined in the USP. It is manufactured by Cadila Healthcare Ltd in Ahmedabad, India.*
figure - 501b1d9e de62 4f0c 9233 fa7af6df2057 03
This is a description of extended-release tablets containing minocycline hydrochloride USP equivalent to minocycline 80 mg. The tablets should be stored at 20° to 25°C (68° to 77°F), protected from light, moisture, and excessive heat as per USP Controlled Room Temperature. The dosage instructions can be found in the package insert, and the tablets should be stored in a tight, light-resistant container. The manufacturer is Cadila Healthcare Ltd. The text mentions that the organic impurities procedure for minocycline USP is still pending. It also warns to keep the medication out of children's reach.*
figure - 501b1d9e de62 4f0c 9233 fa7af6df2057 04
This is a medication used to treat bacterial infections. It comes in a pack of 100 extended-release tablets with each tablet containing minocycline hydrochloride USP equivalent to minocycline 90 mg. The usual dosage should be taken as per the package insert. It must be stored at 20° to 25°C (68° to 77°F) and protected from light, moisture, and excessive heat. The manufacturer is Cadila Healthcare Ltd located in Ahmedabad, India. There is a pending procedure for organic impurities in minocycline USP, and this medication should be kept away from children.*
figure - 501b1d9e de62 4f0c 9233 fa7af6df2057 05
This is a medication containing minocycline hydrochloride USP in extended-release tablet form. Each tablet has 105 mg of minocycline hydrochloride USP. The organic impurities procedure is still pending for minocycline hydrochloride USP. It should be stored in a tight, light-resistant container as per USP and kept out of reach of children. The manufacturer of this medication is Cadila Healthcare Ltd, located in India.*
figure - 501b1d9e de62 4f0c 9233 fa7af6df2057 06
This is a medication called minocycline hydrochloride that is in extended-release tablet form. Each tablet contains 135mg of minocycline. There is a pending procedure for testing organic impurities within the medication. The recommended dosage is available in the package insert. The tablets should be stored between 20°C and 25°C and protected from light, moisture and heat. It should be dispensed in a light-resistant container as defined by the USP. This medication should be kept out of the reach of children. It is manufactured by Cadila Healthcare Ltd and contains 100 tablets. The location of manufacturing is in Ahmedzbad, India and requires a prescription to purchase.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.